BackCelyad Oncology Overview

Celyad Oncology Cost of Revenue

Cost of Revenue analysis for CYAD.

Quarterly Cost of Revenue

$3000.00
↓ 88% YoY

As of Dec 31, 2024

Annual Cost of Revenue (TTM)

$478000.00

Trailing 12 months ending Dec 31, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin